European Industry, Academia Watch Closely As EPO Weighs Legality of WARF hESC Claims

Fresh from closing the books on the validity of its seminal human embryonic stem cell patents in the US, the Wisconsin Alumni Research Foundation is now waiting for the top European patent authority to determine the patentability of related claims in the European Union. The decision could have a wide-ranging impact on how future hESC-based therapies and research tools are sold in Europe.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.